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This review explores the current understanding of the 
immunomodulatory effects of exercise, and the 
effectiveness of utilizing exercise as a therapy for cancer. 
Physical exercise has been shown to reduce the risk of 
developing cancer and appears to possess tumor-suppressive 
capabilities in existing solid tumors by modulating the 
tumor immune microenvironment. The current literature 
suggests exercise to enhance intra-tumoral tumor-
suppressive immune cell activity through multiple 
pathways. The immunomodulating capabilities of exercise 
are likely dependent on anti-tumor immunity pathways. 
Exercise appears to be a viable tumor-suppressive strategy, 
depending on the state of anti-tumor immunity. 
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INTRODUCTION 
The tumor microenvironment has been characterized by 
the presence of tumor and non-tumor cells, including 
immune cells1. Essentially all solid tumors have adjacent 
or infiltrating subsets of immune cells2, implicating the 
immune system to be an excellent target for tumor-
suppressing therapy. Although clinical trials confirm the 
efficacy of immunomodulating therapies, they also show 
high inter-patient variability3. The differences in efficacy 
have been attributed to variables affecting the tumor 
immune microenvironment (TIME) composition4.  
Exercise is one of the most well-studied lifestyle variables 
and shown to be associated with decreased risk of cancer 
development5. The protective effect of exercise can be, 
amongst others, attributed to its effect on immune 
function6. Although exercise itself is not capable of 
eradicating existing tumors, the current literature suggests 
a possible tumor-suppressive effect7. To establish a better 
understanding of the relationship between exercise and the 
TIME this review will provide an overview of the exercise-
induced changes on the TIME and their implications for 
future utilization of exercise as a therapy for cancer 
patients. 
METHODS 
The literature search was conducted through PubMed, 
which offers biomedical- and life-sciences-related literature. 
Search queries included terms related to exercise, 
immunology and microenvironment. The usability of 
articles was judged on the subsequent reading of title, 





Tumor immune microenvironment characterization 
Immune cells interact with tumor cells, displaying both 
tumor-promoting and tumor-suppressive effects8. Although 
the TIME is considered to be a context-dependent dynamic 
environment, parts of the immune presence can be 
characterized based on their distinct tumor-suppressive or 
tumor-promoting effects.  
Three different types of immune cells have been characterized 
to elicit tumor-suppressive effects. Monocytes are recruited to 
the tumor microenvironment and differentiate into tumor-
associated macrophages (TAM), which are able to induce 
tumor-suppressive signaling in case they are M1-polarized by 
for example IFN-γ8–11. Cytotoxic T-lymphocytes (CTL) 
display the greatest tumor-suppressing capabilities of the 
adaptive immune system through their granular secretion of 
cytotoxic compounds, which are able to induce apoptosis in 
tumor-cells12. The presence of T-lymphocytes has been 
associated with a good prognosis of cancer in many tumors13. 
Lastly, natural-killer cells (NK-cells) display specific tumor-
suppressive effects due to their ability to lyse tumor cells14. 
Similarly, three types of immune cells have been 
characterized to elicit tumor-promoting effects. The 
previously mentioned macrophages are also able to polarize 
towards M2 macrophages in response to cytokines, like IL-4, 
IL-10, IL-13, and glucocorticoids, which are associated with 
tumor-promoting signaling10,11,15. Myeloid-derived 
suppressor cell (MDSC) presence has been associated with 
poor prognosis and decreased treatment efficacy, rendering 
them tumor-promoting16. Finally, regulatory T-cells (T-reg) 
have been shown to attenuate the cytotoxicity of CTLs and 
NK-cells, and reduce the antigen presentation by dendritic 
cells16,17. The presence and characteristics of all these immune 
cells in the tumor microenvironment makes them an excellent 
target for immunomodulation. 
 
Tumor immune microenvironment variability 
Categorization of tumors based on their TIME might predict 
the effectiveness of immunomodulating therapies4. The 
infiltrated-excluded tumor immune microenvironment (IE-
TIME) is characterized by the lack of CTL infiltration into 
the tumor, which is suggested to be the result of TAM 
signaling4,18. These types of tumors are considered to display 
a low reactivity to immunomodulating therapies8. In 
contrast, infiltrated-included tumor immune 
microenvironments (II-TIME) are characterized by a high 
number of infiltrating CTLs into the tumor core4. Given the 
ability of immune cells to infiltrate the tumor 
microenvironment of II-TIMEs, these tumors are likely 
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Tumor immune microenvironment differentiation  
Understanding the possible causes of the variability in 
immune cell infiltration into the tumor microenvironment 
could have implications for estimating the effectiveness of 
exercise as an immunomodulating-therapy. A lot of 
research emerged showing genotypical or phenotypical 
discrepancies between tumors4. These discrepancies result 
in a state of anti-tumor immunity which might be 
responsible for the TIME-regulation and variability. An 
example of anti-tumor immunity is the expression of 
Programmed death-ligand 1 by tumor cells, which 
downregulated CTL activity, resulting in a powerful 
immune-suppressive effect19,20. As exercise is not known 
to modulate anti-tumor immunity, tumors significantly 
displaying these traits are unlikely to respond to 
immunomodulation by exercise on its own. The currently 
available immunotherapies have been shown to modulate 
anti-tumor immunity20, and could therefore possibly 
increase the efficacy of exercise as an immunomodulatory 
therapy when used concurrently. 
The direct effects of exercise on the tumor immune 
microenvironment 
A body of evidence has started to develop suggesting 
exercise itself to suppress tumor growth and improve the 
prognosis of several types of cancer7, possibly in part due 
to the immunomodulating effects of exercise (Figure 1). 
Animal research shows exercise to enhance the activity of 
macrophages by increasing their presence in a 
catecholamine-dependent manner and supporting their 
effector functions via increased levels of Tumor Necrosis 
Factor alpha (TNF-α) (Figure 1, A and C)21,22. Indirect 
measurements of TAM polarization in mice suggest 
exercise to induce the tumor-suppressive M1 phenotype 
(Figure 1A)22,23. Exercise in mice appears to induce 
catecholamine-dependent recruitment of NK-cell (Figure 
1A), which are activated and homed towards the tumor by 
IL-6 dependent pathways (Figure 1C)24. This particular 
paper found the exercise-induced increase in NK-cell 
activity to decrease tumor growth by 60%24. In mouse 
models, exercise-induced increases in catecholamines also 
upregulate the CTL mobilization (Figure 1A)24. The same 
study displayed increased tumor growth in athymic mice, 
marking the importance of CTLs as tumor-suppressors. 
Mouse models also display exercise-induced attenuation in 
T-reg levels, accompanied by decreased tumor growth 
(Figure 1B)23. The exercise-induced tumor-suppressive 
effects appeared to be dose-dependent23. 
Besides increases in circulating CTL numbers, the 
cytotoxic capabilities of CTLs were also suggested to be 
upregulated, marked by the increased levels of IL-1, and 
IL-2 in exercised mice (Figure 1C)25. The effects of 
exercise on IL-1 and IL-2 production appeared dose-
dependent, as the group of mice performing the most 
exercise displayed the greatest effects. Exercise has been 
shown to upregulate lactate transporter genes in humans, 
to counteract the exercise-induced lactate production26. 
These effects possibly attenuated the tumor-induced 
lactate concentrations, as CTLs activity was completely 
diminished in vitro when exposed to tumoral lactic acid 
concentrations (Figure 1B)27. In summary, exercise 
appears to induce physiological adaptations which could 












The indirect effects of exercise on the tumor immune 
microenvironment 
 
Besides from exercise directly affecting the activity of the 
immune system, exercise is known to induce physiological 
adaptations which could support the immunomodulating 
effects (Figure 2). Upon performing exercise, cardiac output 
is increased and the blood is redistributed to facilitate the 
exercise-induced changes in the need for substrates by 
different organs (Figure 2A). Surprisingly, a single bout of 
exercise appears to increase the intratumoral blood flow by 
200% in mouse-prostate tumors, whilst the surrounding 
tissues do not experience an increase in blood flow (Figure 
2A)28. Alterations in the tumor blood-flow might have an 
impact on tumor development, by changing the quantity of 
perfused oxygen, immune cells, and therapeutic substances. 
  
Apart from the increase in blood flow, the increase in mean 
arterial pressure by exercise may enhance the tumor blood 
perfusion (Figure 2B)29. In contrast to a normal blood vessel, 
tumor vasculature is both heterogeneous and tortuous30. 
Normalizing the tumor vasculature structure and functionality 
could possibly increase the infiltration of oxygen, drugs, and 
immune cells into a tumor30. Tumors of exercised mice 
display a 2,5-fold increase in blood perfused area31, 
suggesting exercise to normalize the tumor vasculature 
(Figure 2B). The actual effect of improved perfusion was 
tested by assigning chemotherapy to some of the mice, which 
found increased efficacy of the chemotherapy when combined 
with exercise31. This experiment led to some additional 
findings, as exercise-only and chemotherapy-only groups 
experienced the same tumor growth inhibition, confirming 
exercise has a growth-inhibiting effect on its own31. Physical 
activity in itself is able to increase the core body temperature, 
which is able to support immune cell infiltration via high 
endothelial venules (HEV) (Figure 2C), possibly attenuating 
tumor growth32,33. In summary, exercise appears to indirectly 






Figure 1. Schematic overview of the direct effects of exercise on 
the Tumor Immune Microenvironment. 
Figure 2. Schematic overview of the indirect effects of exercise 
on the Tumor Immune Microenvironment. 
DISCUSSION 
A important effect of exercise on the TIME appears to be 
catecholamine-dependent, as exercise-induced elevations in 
catecholamines increase tumor-suppressive immune 
activity. However, exercise-independent elevations in 
catecholamines do not appear to fully replicate the tumor-
suppressive effects of exercise, indicating additional 
mechanisms to be involved. In case of NK-cells, these 
discrepancies appear to be caused by the exercise-induced 
release of IL-6, which provides a means of activating the 
catecholamine-mobilized NK-cells. Pedersen and 
colleagues (2016) attributed the tumor-suppressive effects 
of exercise to elevated NK-cell activity, as athymic mice 
displayed similar tumor-suppression. Based on the current 
understanding of the TIME, this attribution is reasonable, as 
intratumoral NK-cell abundance experiences the largest fold 
increase of all immune cells upon performing exercise. The 
importance of the indirect effects of exercise on the TIME 
requires further elucidation, although these physiological 
adaptations are likely to increase the efficacy of 
conventional cancer treatments. The significance of exercise 
as an immunomodulating therapy is likely to be affected by 
anti-tumor immunity, marking the importance of the TIME 
characterization. Tumors displaying high activity of anti-
tumor immunity pathways are likely to have an IE-TIME, 
whilst low activity suggests an II-TIME. Given the specific 
immunomodulating effects of exercise, these are likely to be 
most effective in II-TIMEs.  
 
Most of the studies showing a tumor-suppressive effect of 
exercise have utilized mouse models in which the tumor 
cells were introduced, which may not be fully representative 
of a human cancer situation. Cancer often develops as a co-
morbidity in people, suggesting decreased metabolic health. 
Metabolic dysregulation may affect the effects of exercise 



































In addition, in a clinical setting most cancer patients would 
present with a long-established tumor, and are more likely to 
have developed a form of anti-tumor immunity. These 
discrepancies between mouse experiments and with a clinical 
case of cancer, suggest the need for a more representative 
models. The current indications of a dose-dependent effect of 
exercise as therapeutic treatment requires future studies to 
elucidate the variables in exercise efficacy as current studies 
mainly implemented voluntary wheel-running. These 
variables would include the effects of exercise intensity, 
frequency, timing, and duration. Refining the research model 
and exercise parameters would increase the understanding of 
exercise as a therapeutic strategy.  
 
CONCLUSION 
Current research suggests exercise to enhance the tumor-
suppressive capabilities of the TIME (Figure 3.). These 
effects are mainly attributed to a catecholamine-dependent 
immune cell mobilization, combined with cytokine-
dependent enhanced immune cell activity. In addition, several 
exercise-induced adaptations have been identified to support 
the tumor-suppressive capabilities of the TIME. Anti-tumor 
immunity pathways are likely to attenuate the tumor-
suppressive effects of exercise. Therefore, exercise might be 
a viable therapeutic strategy in II-TIMEs, while concurrently 
receiving conventional immunomodulating therapy. 
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Figure 2. The Exercise-Induced Effects on the Tumor Immune Microenvironment. This illustration encompasses the currently 
identified immunomodulating effects of exercise on the tumor immune microenvironment. 
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